Patent US4668399A successfully refreshed from Google Patents.
US4668399A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Hollow fiber plasmapheresis process
Assignee: EIDP Inc
•
Filing: 1982-12-16
•
Granted: 1987-05-26
•
Expires: 2002-12-16
Abstract
Abstract Hollow fiber plasmapheresis module and process, said module comprising hollow fibers having cell-retaining pores and an effective length (L) to lumen diameter (D) ratio L/D not greater than 16,400 cm -1 D (L and D being in centimeters) within a housing having a blood inlet for conducting blood to the fibers, an outlet for conducting exit (plasma-depleted) blood from the fibers, and a plasma outlet for conducting plasma out of the module.
Inventors
- 👤 Ray B. Duggins
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-24 22:54
CPC Classifications
B; B01; B01D; B01D63/00; B01D63/02; A; A61; A61M; A61M1/00; A61M1/34; A61M1/3403; A61M1/3496; A61M1/36; A61M1/3601; A61M1/3603; A61M1/3604; A61M60/00; A61M60/10; A61M60/104; A61M60/109; A61M60/20; A61M60/247; A61M60/253; A61M60/268; A61M60/279; A61M60/30; A61M60/36; A61M60/37; A61M60/40; A61M60/424; A61M60/438; A61M60/80; A61M60/845; A61M60/851; A61M60/853; B01D61/00; B01D61/14; B01D61/147; B01D65/00; B01D65/08; A61M1/3621; A61M1/3623; A61M2205/00; A61M2205/33; A61M2205/3306; A61M2205/3331; A61M2205/3334; A61M60/113; B01D2321/00; B01D2321/20; B01D2321/2066; B01D2321/2083
Claims Analysis
Total Claims: 13
Claim 1
Independent Claim
246 words
Improved method for plasmapheresis carried out in a system with a bundle consisting of a plurality of blood wettable porous membrane hollow fibers all of which are in parallel bundle alignment and have a substantially uniform membrane pore diameter and open inlet ends and open outlet ends, each fiber having a lumen diameter (D) no greater than 0.050 cm, the pore diameter being within the range 0.1 to 1.0 μm, comprising: (a) conducting blood in a forward direction into and through the fibers while maintaining a mean positive transmembrane pressure difference across the membranes from inlets to outlets of the hollow fibers; (b) terminating the forward conducting of blood; (c) conducting blood through the hollow fibers in the reverse direction; (d) collecting plasma-depleted blood from the outlets of the hollow fibers; (e) collecting plasma which has passed through the pores of the membranes; and (f) repeating in sequence steps (a), (b) and (c) to collect additional plasma-depleted blood and plasma, the effective length, that is, the portion of each fiber, between the ends, through which plasma passes, of the hollow fibers being such that the L/D ratio is no greater than 16,400 cm -1 D (L and D being in centimeters) and the velocity of the blood in step (a) being such that the shear rate is 200 to 2500 sec -1 , the improved method providing a plasma flux of at least 0.042 mL/min/cm 2 and an outlet plasma-depleted blood hematocrit of at least 65%.
Claim 2
Dependent Claim
246 words
Improved method for plasmapheresis carried out in a system with a bundle consisting of a plurality of blood wettable porous membrane hollow fibers all of which are in parallel bundle alignment and have a substantially uniform membrane pore diameter and open inlet ends and open outlet ends, each fiber having a lumen diameter (D) no greater than 0.050 cm, the pore diameter being within the range 0.1 to 1.0 μm, comprising: (a) conducting blood in a forward direction into and through the fibers while maintaining a mean positive transmembrane pressure difference across the membranes from inlets to outlets of the hollow fibers; (b) terminating the forward conducting of blood; (c) conducting blood through the hollow fibers in the reverse direction; (d) collecting plasma-depleted blood from the outlets of the hollow fibers; (e) collecting plasma which has passed through the pores of the membranes; and (f) repeating in sequence steps (a), (b) and (c) to collect additional plasma-depleted blood and plasma, the effective length, that is, the portion of each fiber, between the ends, through which plasma passes, of the hollow fibers being such that the L/D ratio is no greater than 16,400 cm -1 D (L and D being in centimeters) and the velocity of the blood in step (a) being such that the shear rate is 200 to 2500 sec -1 , the improved method providing a plasma flux of at least 0.042 mL/min/cm 2 and an outlet plasma-depleted blood hematocrit of at least 65%.
Claim 3
Dependent Claim
30 words
Method of claim 1 wherein the lumen diameter (D) is 0.015 to 0.050 cm and the pore size of the porous membrane is within the range 0.4 to 0.6 μm.
Claim 4
Dependent Claim
15 words
Method of claim 2 wherein the shear rate is 1000 to 2500 sec -1 .
Claim 5
Dependent Claim
14 words
Method of claim 2 wherein the L/D ratio is not greater than about 540.
Claim 6
Dependent Claim
14 words
Method of claim 2 wherein the L/D ratio is about 100 to about 350.
Claim 7
Dependent Claim
12 words
Method of claim 1 wherein the fibers are blood wettable polypropylene fibers.
Claim 8
Dependent Claim
39 words
Method of claim 1 which includes as an additional feature: conducting blood in an external circuit from a region near the inlets or outlets of the fibers to a region near, respectively, the outlets or inlets of the fibers.
Claim 9
Dependent Claim
24 words
Method of claim 1 wherein the volume of blood conducted in step (a) is different from the volume of blood conducted in step (c).
Claim 10
Dependent Claim
24 words
Method of claim 8 wherein the volume of blood conducted in step (a) is greater than the volume of blood conducted in step (c).
Claim 11
Dependent Claim
30 words
Method of claim 1 wherein the volume of blood conducted in either step (a) or step (c) is at least 5% of the total volume of blood in the system.
Claim 12
Dependent Claim
33 words
Method of claim 1 wherein the transmembrane pressure difference across part of the membrane hollow fibers is negative for part of the distance that the blood is conducted across the membrane hollow fibers.
Claim 13
Dependent Claim
55 words
Method of claim 11 wherein the arithmetic product of: (a) the time-average of the transmembrane pressure while it is positive in a portion of the membrane hollow fibers and (b) the time in that portion of the membrane hollow fiber, is numerically greater, indenpendently of sign, than such product when the transmembrane pressure is negative.
References Cited (Backward Citations)
US3342729A
Cited
GB1381410A
Cited
US4075091A
Cited
US3853756A
Cited
US4001117A
Cited
US4247498A
Cited
US4191182A
Cited
US4343705A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1990-05-25 | 1990-11-24 | 1991-05-26 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1994-05-25 | 1994-11-24 | 1995-05-26 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1998-05-25 | 1998-11-24 | 1999-05-26 | $7700.00 | Window Closed / Lapsed |